Vitrakvi Solution, Concentrate
Product Images NDC 50419-393

22 FDA label images from Bayer Healthcare Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Vitrakvi (NDC 50419-393). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vitrakvi 01)

Chemical Structure (Vitrakvi 01)
Chemical structure of larotrectinib, the active ingredient in VITRAKVI capsules. The diagram shows the molecular framework including fluorinated phenyl, pyrrolidine, and triazolopyridine components.*
FDA Label Image

Chemical Structure (Vitrakvi 02)

Chemical Structure (Vitrakvi 02)
An instructional illustration showing VITRAKVI oral liquid packaging components, including a bottle with a cap, a bottle adaptor, and individually wrapped 5 mL and 1 mL oral syringes for dosing.*
FDA Label Image

Chemical Structure (Vitrakvi 03)

Chemical Structure (Vitrakvi 03)
An instructional illustration showing hands opening a capped bottle by pressing down and turning the cap, demonstrating the action needed to open a child-resistant closure for a prescription drug container.*
FDA Label Image

Chemical Structure (Vitrakvi 04)

Chemical Structure (Vitrakvi 04)
An instructional diagram showing how to apply a cap onto a bottle. The image depicts one bottle with an open neck and an arrow indicating placement of the cap, and another bottle with the cap securely closed. No specific product labeling or text is visible in this black-and-white line drawing.*
FDA Label Image

Chemical Structure (Vitrakvi 05)

Chemical Structure (Vitrakvi 05)
An instructional diagram showing detailed views of oral syringes and their components. The image includes labeled parts of a 1 mL oral syringe (tip, barrel, flange, plunger) and a 5 mL oral syringe. Both syringes show volume markings for accurate liquid measurement.*
FDA Label Image

Chemical Structure (Vitrakvi 06)

Chemical Structure (Vitrakvi 06)
An instructional illustration showing a hand using a syringe to withdraw liquid from a vial held by the other hand, with a downward arrow indicating the syringing action toward the vial.*
FDA Label Image

Chemical Structure (Vitrakvi 07)

Chemical Structure (Vitrakvi 07)
An instructional diagram showing how to use a syringe to measure liquid medication. One hand holds a bottle upside down while the other pulls the syringe plunger downward to draw liquid. A zoomed-in view highlights parts of the syringe including the tip, barrel, plunger, and measurement markings to the top of the plunger. This illustrates proper technique for accurate dosing measurement.*
FDA Label Image

Chemical Structure (Vitrakvi 08)

Chemical Structure (Vitrakvi 08)
An instructional line drawing showing how to remove air bubbles from a syringe filled from a medication vial. The illustration depicts one hand holding the vial upside down, the other hand holding the syringe, with an arrow indicating air bubbles being pushed out from the syringe.*
FDA Label Image

Chemical Structure (Vitrakvi 09)

Chemical Structure (Vitrakvi 09)
An illustration showing two hands preparing a medication dose by inserting a syringe into a vial. The image depicts the action of drawing liquid into the syringe by pulling it upward from the vial held by another hand, likely demonstrating the preparation of an oral liquid medication dose.*
FDA Label Image

Chemical Structure (Vitrakvi 10)

Chemical Structure (Vitrakvi 10)
An instructional black-and-white line drawing showing a hand administering oral medication to a baby using an oral syringe. The syringe is positioned inside the baby's mouth, directed towards the side. An arrow indicates the forward motion of the syringe during administration.*
FDA Label Image

Chemical Structure (Vitrakvi 11)

Chemical Structure (Vitrakvi 11)
An instructional illustration showing two hands opening a bottle by twisting the cap counterclockwise. The image emphasizes proper technique for opening a child-resistant or safety cap bottle.*
FDA Label Image

Chemical Structure (Vitrakvi 12)

Chemical Structure (Vitrakvi 12)
An instructional diagram showing two hands holding parts of a device or container, demonstrating the action to pull or separate the parts apart, indicated by double-headed arrows pointing left and right.*
FDA Label Image

Chemical Structure (Vitrakvi 13)

Chemical Structure (Vitrakvi 13)
An instructional illustration showing a hand holding a syringe-like applicator under running water from a faucet. A second, similar applicator is dripping liquid next to it. This image likely demonstrates the rinsing or cleaning of the applicator before use.*
FDA Label Image

Chemical Structure (Vitrakvi 14)

Chemical Structure (Vitrakvi 14)
An instructional illustration showing two different types of oral dosing syringes. Syringe 1 has a plunger with a finger grip, and Syringe 2 is a simpler oral dosing syringe without finger grips. The image likely demonstrates types of oral syringes used for liquid medication administration.*
FDA Label Image

Chemical Structure (Vitrakvi 15)

Chemical Structure (Vitrakvi 15)
An instructional illustration showing hand-held syringes being used for liquid preparation or administration. The first step depicts drawing up liquid by pulling the plunger upward in a bowl or dish, and the second step shows expelling liquid by pressing the plunger downward, with arrows indicating directions of movement.*
FDA Label Image

Chemical Structure (Vitrakvi 16)

Chemical Structure (Vitrakvi 16)
An instructional illustration showing a hand holding a syringe under running water from a faucet, with another syringe positioned next to it, both syringes dripping liquid. This diagram likely demonstrates the rinsing or cleaning of syringes.*
FDA Label Image

Chemical Structure (Vitrakvi 17)

Chemical Structure (Vitrakvi 17)
An instructional line drawing showing a hand manipulating a syringe or dosing device, with arrows indicating movement and liquid droplets to suggest expelling or measuring liquid. The image appears to demonstrate the proper technique for preparing or administering an oral liquid medication dose.*
FDA Label Image

Chemical Structure (Vitrakvi 18)

Chemical Structure (Vitrakvi 18)
An illustration showing a person writing the date "4/11" on a medication bottle label under the heading "Date of First Opening." The image demonstrates recording the opening date on a prescription drug container.*
FDA Label Image

Image Of 25 mg Label Principal Panel (60 capsules)

Image Of 25 mg Label Principal Panel (60 capsules)
VITRAKVI (larotrectinib) capsules 25 mg label displays the Bayer logo and states the product is for prescription use only. It includes storage instructions, the package quantity of 60 capsules, and manufacturing information for Bayer HealthCare Pharmaceuticals Inc. Barcode and NDC 50419-390-01 are visible.*
FDA Label Image

Image Of 100 mg Label Principal Panel (60 capsules)

Image Of 100 mg Label Principal Panel (60 capsules)
VITRAKVI 100 mg capsules label showing the oral human prescription drug larotrectinib. The label highlights dosage strength, manufacturer Bayer HealthCare Pharmaceuticals Inc., storage instructions, and a barcode. Each capsule contains 100 mg larotrectinib (123 mg larotrectinib sulfate equivalent).*
FDA Label Image

Image Of 20 mg/ml Label Principal Panel (100 mL oral solution)

Image Of 20 mg/ml Label Principal Panel (100 mL oral solution)
VITRAKVI (larotrectinib) oral solution 20 mg/mL label from Bayer HealthCare Pharmaceuticals Inc. The label specifies storage instructions, usage precautions, and volume (100 mL). It includes barcodes and regulatory details indicating prescription-only status and refrigeration requirements.*
FDA Label Image

Package Label (20 mg/mL)

Package Label (20 mg/mL)
Label for VITRAKVI (larotrectinib) oral solution 20 mg/mL by Bayer HealthCare Pharmaceuticals Inc. The label includes storage instructions (refrigerate, do not freeze), dosage form (50 mL oral solution), and usage notes emphasizing oral administration only and a 31-day discard period after first opening. The label also provides lot and expiration date fields, as well as a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.